Report Detail

Service & Software Global Cancer Cell Biopsy Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4506754
  • |
  • 04 February, 2023
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Cancer Cell Biopsy Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cancer Cell Biopsy Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cancer Cell Biopsy Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cancer Cell Biopsy Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cancer Cell Biopsy Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cancer Cell Biopsy Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Cell Biopsy Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Cell Biopsy Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ANGLE, Fluxion Biosciences, Inivata, GRAIL and Guardant Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cancer Cell Biopsy Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Incisional Biopsy
Needle Biopsy
Market segment by Application
Hospital
Clinic
Market segment by players, this report covers
ANGLE
Fluxion Biosciences
Inivata
GRAIL
Guardant Health
Caris
Liquid Biopsy Labs
DermTech
QIAGEN
Lucence
Biocept
CELLSEARCH
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Cell Biopsy Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Cell Biopsy Service, with revenue, gross margin and global market share of Cancer Cell Biopsy Service from 2018 to 2023.
Chapter 3, the Cancer Cell Biopsy Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cancer Cell Biopsy Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Cell Biopsy Service.
Chapter 13, to describe Cancer Cell Biopsy Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Cell Biopsy Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer Cell Biopsy Service by Type
    • 1.3.1 Overview: Global Cancer Cell Biopsy Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cancer Cell Biopsy Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Incisional Biopsy
    • 1.3.4 Needle Biopsy
  • 1.4 Global Cancer Cell Biopsy Service Market by Application
    • 1.4.1 Overview: Global Cancer Cell Biopsy Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Cancer Cell Biopsy Service Market Size & Forecast
  • 1.6 Global Cancer Cell Biopsy Service Market Size and Forecast by Region
    • 1.6.1 Global Cancer Cell Biopsy Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cancer Cell Biopsy Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Cancer Cell Biopsy Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cancer Cell Biopsy Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cancer Cell Biopsy Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cancer Cell Biopsy Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cancer Cell Biopsy Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 ANGLE
    • 2.1.1 ANGLE Details
    • 2.1.2 ANGLE Major Business
    • 2.1.3 ANGLE Cancer Cell Biopsy Service Product and Solutions
    • 2.1.4 ANGLE Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 ANGLE Recent Developments and Future Plans
  • 2.2 Fluxion Biosciences
    • 2.2.1 Fluxion Biosciences Details
    • 2.2.2 Fluxion Biosciences Major Business
    • 2.2.3 Fluxion Biosciences Cancer Cell Biopsy Service Product and Solutions
    • 2.2.4 Fluxion Biosciences Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Fluxion Biosciences Recent Developments and Future Plans
  • 2.3 Inivata
    • 2.3.1 Inivata Details
    • 2.3.2 Inivata Major Business
    • 2.3.3 Inivata Cancer Cell Biopsy Service Product and Solutions
    • 2.3.4 Inivata Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Inivata Recent Developments and Future Plans
  • 2.4 GRAIL
    • 2.4.1 GRAIL Details
    • 2.4.2 GRAIL Major Business
    • 2.4.3 GRAIL Cancer Cell Biopsy Service Product and Solutions
    • 2.4.4 GRAIL Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 GRAIL Recent Developments and Future Plans
  • 2.5 Guardant Health
    • 2.5.1 Guardant Health Details
    • 2.5.2 Guardant Health Major Business
    • 2.5.3 Guardant Health Cancer Cell Biopsy Service Product and Solutions
    • 2.5.4 Guardant Health Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Guardant Health Recent Developments and Future Plans
  • 2.6 Caris
    • 2.6.1 Caris Details
    • 2.6.2 Caris Major Business
    • 2.6.3 Caris Cancer Cell Biopsy Service Product and Solutions
    • 2.6.4 Caris Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Caris Recent Developments and Future Plans
  • 2.7 Liquid Biopsy Labs
    • 2.7.1 Liquid Biopsy Labs Details
    • 2.7.2 Liquid Biopsy Labs Major Business
    • 2.7.3 Liquid Biopsy Labs Cancer Cell Biopsy Service Product and Solutions
    • 2.7.4 Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Liquid Biopsy Labs Recent Developments and Future Plans
  • 2.8 DermTech
    • 2.8.1 DermTech Details
    • 2.8.2 DermTech Major Business
    • 2.8.3 DermTech Cancer Cell Biopsy Service Product and Solutions
    • 2.8.4 DermTech Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 DermTech Recent Developments and Future Plans
  • 2.9 QIAGEN
    • 2.9.1 QIAGEN Details
    • 2.9.2 QIAGEN Major Business
    • 2.9.3 QIAGEN Cancer Cell Biopsy Service Product and Solutions
    • 2.9.4 QIAGEN Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 QIAGEN Recent Developments and Future Plans
  • 2.10 Lucence
    • 2.10.1 Lucence Details
    • 2.10.2 Lucence Major Business
    • 2.10.3 Lucence Cancer Cell Biopsy Service Product and Solutions
    • 2.10.4 Lucence Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Lucence Recent Developments and Future Plans
  • 2.11 Biocept
    • 2.11.1 Biocept Details
    • 2.11.2 Biocept Major Business
    • 2.11.3 Biocept Cancer Cell Biopsy Service Product and Solutions
    • 2.11.4 Biocept Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Biocept Recent Developments and Future Plans
  • 2.12 CELLSEARCH
    • 2.12.1 CELLSEARCH Details
    • 2.12.2 CELLSEARCH Major Business
    • 2.12.3 CELLSEARCH Cancer Cell Biopsy Service Product and Solutions
    • 2.12.4 CELLSEARCH Cancer Cell Biopsy Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 CELLSEARCH Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer Cell Biopsy Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cancer Cell Biopsy Service by Company Revenue
    • 3.2.2 Top 3 Cancer Cell Biopsy Service Players Market Share in 2022
    • 3.2.3 Top 6 Cancer Cell Biopsy Service Players Market Share in 2022
  • 3.3 Cancer Cell Biopsy Service Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer Cell Biopsy Service Market: Region Footprint
    • 3.3.2 Cancer Cell Biopsy Service Market: Company Product Type Footprint
    • 3.3.3 Cancer Cell Biopsy Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer Cell Biopsy Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cancer Cell Biopsy Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cancer Cell Biopsy Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cancer Cell Biopsy Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cancer Cell Biopsy Service Consumption Value by Type (2018-2029)
  • 6.2 North America Cancer Cell Biopsy Service Consumption Value by Application (2018-2029)
  • 6.3 North America Cancer Cell Biopsy Service Market Size by Country
    • 6.3.1 North America Cancer Cell Biopsy Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cancer Cell Biopsy Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Cancer Cell Biopsy Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Cancer Cell Biopsy Service Market Size by Country
    • 7.3.1 Europe Cancer Cell Biopsy Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Cell Biopsy Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cancer Cell Biopsy Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cancer Cell Biopsy Service Market Size by Region
    • 8.3.1 Asia-Pacific Cancer Cell Biopsy Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cancer Cell Biopsy Service Consumption Value by Type (2018-2029)
  • 9.2 South America Cancer Cell Biopsy Service Consumption Value by Application (2018-2029)
  • 9.3 South America Cancer Cell Biopsy Service Market Size by Country
    • 9.3.1 South America Cancer Cell Biopsy Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Cell Biopsy Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cancer Cell Biopsy Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cancer Cell Biopsy Service Market Size by Country
    • 10.3.1 Middle East & Africa Cancer Cell Biopsy Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cancer Cell Biopsy Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cancer Cell Biopsy Service Market Drivers
  • 11.2 Cancer Cell Biopsy Service Market Restraints
  • 11.3 Cancer Cell Biopsy Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Cancer Cell Biopsy Service Industry Chain
  • 12.2 Cancer Cell Biopsy Service Upstream Analysis
  • 12.3 Cancer Cell Biopsy Service Midstream Analysis
  • 12.4 Cancer Cell Biopsy Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Cell Biopsy Service. Industry analysis & Market Report on Cancer Cell Biopsy Service is a syndicated market report, published as Global Cancer Cell Biopsy Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cancer Cell Biopsy Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,773.56
    4,160.34
    5,547.12
    3,236.40
    4,854.60
    6,472.80
    532,022.40
    798,033.60
    1,064,044.80
    290,336.40
    435,504.60
    580,672.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report